Literature DB >> 22006149

Localized skin necrosis of steroid-induced striae distensae: an unusual complication of bevacizumab and irinotecan therapy.

Sabrina Fourcade, Caroline Gaudy-Marqueste, Anne-Marie Tasei, Marie-Aleth Richard, Jean-Jacques Grob.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006149     DOI: 10.1001/archdermatol.2011.311

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  4 in total

Review 1.  Use of bevacizumab in recurrent glioblastoma.

Authors:  Ashley Ghiaseddin; Katherine B Peters
Journal:  CNS Oncol       Date:  2015-04-23

Review 2.  Management of Dermatologic Complications of Lung Cancer Therapies.

Authors:  Silvina B Pugliese; Joel W Neal; Bernice Y Kwong
Journal:  Curr Treat Options Oncol       Date:  2015-10

Review 3.  Restorative oncodermatology: Diagnosis and management of dermatologic sequelae from cancer therapies.

Authors:  Anthony M Rossi; Brian P Hibler; Cristian Navarrete-Dechent; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2020-08-08       Impact factor: 15.487

4.  Necrotic ulcerated and bleeding striae distensae following bevacizumab in a palliative setting for gliobastomatosis cerebri.

Authors:  Olivia Laugier; Laetitia Padovani; Arnauld Verschuur; Caroline Gaudy-Marqueste; Nicolas André
Journal:  Ecancermedicalscience       Date:  2017-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.